Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM4MRP9)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Patented Agent(s)

Download the Complete Related Drug List

Drug(s) Targeting PIM-3 protein kinase (PIM3)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
US9682991, 23	DMGTIP6	N. A.	N. A.	Patented	[2]
US8889696, Staurosporine	DMSYUHK	N. A.	N. A.	Patented	[3]
US8829193, 3	DM5ZGK3	N. A.	N. A.	Patented	[4]
BDBM50061601	DMQ4TUE	N. A.	N. A.	Patented	[5]
US9580418, Example 8	DMGH9B3	N. A.	N. A.	Patented	[6]
BDBM50061608	DM3MRD9	N. A.	N. A.	Patented	[5]
US8481586, 15	DMFEUMZ	N. A.	N. A.	Patented	[7]
US9434725, 315	DM316FB	N. A.	N. A.	Patented	[8]
BDBM50061612	DMM8IDC	N. A.	N. A.	Patented	[5]
US8669361, 102	DM4G3OC	N. A.	N. A.	Patented	[9]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	Ring-substituted N-pyridinyl amides as kinase inhibitors. US8987457.
2	Tricyclic compounds for use as kinase inhibitors. US9682991.
3	Substituted pyrido[2,3-d]pyrimidin-7(8H)-ones and therapeutic uses thereof. US8889696.
4	PIM kinase inhibitors and methods of their use. US8829193.
5	Azole compounds as PIM inhibitors. US9321756.
6	Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors. US9580418.
7	Pyrrolo[2,3-a] carbazoles and use thereof as PIM kinase inhibitors. US8481586.
8	5-azaindazole compounds and methods of use. US9434725.
9	Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use. US9573943.